| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |